Outlook Therapeutics Inc (NASDAQ:OTLK) does about 490.29K shares in volume on a normal day but saw 916283 shares change hands in the recent trading day. The company now has a market cap of 79.28M USD. Its current market price is $1.85, marking an increase of 4.52% compared to the previous close of $1.77. The 52 week high reached by this stock is $9.25 whilst the lowest price level in 52 weeks is $0.87.
The consensus objective for the share price is $6.33, suggesting that the stock has a potential upside of 70.77% over the period.
FactSet Research has provided data showing that 5 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 5 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
BTIG Research upgraded the stock to “Buy” from Neutral on March 27, 2024 at a price target of $50. Chardan Capital Markets upgraded its price target at $3.
The current price level is 10.68%, 23.28%, and -43.35% away from its SMA20, SMA50, and SMA200 respectively, with the OTLK price moving below the 50-day SMA on current market day. Outlook Therapeutics Inc (OTLK) stock is up 14.91% over the week and 19.35% over the past month. Its price is -2.12% year-to-date and -74.38% over the past year.
To reach the target analysts have set, the stock logically needs to grow 70.77 percent from here.
Outstanding shares total 32.91M with insiders holding 38.31% of the shares and institutional holders owning 16.81% of the company’s common stock. The beta has a value of 0.31.
